Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33229457.
- Also identified by DOI 10.1158/1078-0432.CCR-20-3758 and PMC identifier 7887011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Utilization of telehealth as part of the cancer care delivery continuum dramatically escalated in response to the COVID-19 pandemic at major cancer centers across the globe. The rapid shift toward telehealth visits for nontreatment cancer care provided immediate benefit through reducing unnecessary risk of exposure, overcoming transportation barriers faced by both patients and caregivers, and fast-tracking care transformation. As such, delineating the impact of telehealth on access, health equity, quality, and outcomes will be essential for refining the use of digital strategies and telehealth toward optimizing cancer care. Herein, experiences to date with telehealth usage for oncology care are reviewed, and priorities are outlined for postpandemic opportunities to improve the lives of patients with cancer through telemedicine.
Medical subject headings
- COVID-19
- Medical Oncology
- Neoplasms
- SARS-CoV-2
- Telemedicine